Age-related real-world outcomes for patients (pts) with metastatic colorectal cancer (mCRC).

被引:0
作者
Curtis, Melissa [1 ]
Nussbaum, Nathan Coleman [1 ]
Hamrick, Harvey J. [1 ]
Bennette, Caroline Savage [1 ]
Meropol, Neal J. [1 ]
Miksad, Rebecca A. [1 ]
机构
[1] Flatiron Hlth, New York, NY USA
关键词
D O I
10.1200/JCO.2018.36.15_suppl.3613
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3613
引用
收藏
页数:2
相关论文
共 50 条
[1]   Management of Metastatic Colorectal Cancer (mCRC): Real-World Recommendations [J].
Parikh, Purvish ;
Bahl, Ankur ;
Sharma, Gopal ;
Pramanik, Raja ;
Wadhwa, Jyoti ;
Bajpai, Peush ;
Jandyal, Sunny ;
Dubey, A. P. ;
Sarin, Aditya ;
Dadhich, Subash Chandra ;
Saklani, Avinash P. ;
Kumar, Ashok ;
Chandra, Abhijit ;
Rawat, Saumitra ;
Selvasekar, C. ;
Aggarwal, Shyam .
SOUTH ASIAN JOURNAL OF CANCER, 2024, 13 (04) :287-295
[2]   Real-world treatment patterns and outcomes associated with bevacizumab (bev) in metastatic colorectal cancer (mCRC). [J].
Saverno, Kimberly ;
Walker, Mark S. ;
Hennessy, Daniel ;
Dhawan, Ravinder .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[3]   Real world (RW) use and outcomes of regorafenib (REG) flexible dosing in patients (pts) with metastatic colorectal cancer (mCRC) in Europe [J].
Peeters, Marc ;
Chibaudel, Benoist ;
Barzi, Afsaneh ;
Ostojic, Helene ;
Pan, Xiaoyun ;
Yasuda, Marie ;
Chen, Chi-Chang ;
Multani, Jasjit ;
Casey, Vicky ;
Vassilev, Zdravko .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) :47-47
[4]   Real-world evidence (RWE) on the clinical outcomes in 1st-line chemotherapy (CT) for fit and vulnerable patients (pts) with metastatic colorectal cancer (mCRC) [J].
Yamazaki, K. ;
Yamanaka, T. ;
Hamano, T. .
ANNALS OF ONCOLOGY, 2020, 31 :S431-S431
[5]   Real-world (RW) study in patients (pts) with metastatic colorectal cancer (mCRC) with long-term responses to regorafenib in the USA. [J].
Kim, Richard D. ;
Pan, Xiaoyun ;
Ostojic, Helene ;
Zhang, Yiqiao ;
Lunacsek, Orsolya ;
Pisa, Federica ;
Peeters, Marc .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) :48-48
[6]   A real-world application of liquid biopsy (LB) in metastatic colorectal cancer (mCRC). [J].
Procaccio, Letizia ;
Del Re, Marzia ;
Crucitta, Stefania ;
Gianfilippo, Giulia ;
Daniel, Francesca ;
Di Antonio, Veronica ;
Gallimberti, Sara ;
Munari, Giada ;
Zanella, Giulia ;
Alberti, Giulia ;
Rizzato, Mario Domenico ;
Rasola, Cosimo ;
Maddalena, Giulia ;
Prete, Alessandra Anna ;
Bergamo, Francesca ;
Zagonel, Vittorina ;
Lonardi, Sara ;
Danesi, Romano ;
Fassan, Matteo ;
Loupakis, Fotios .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[7]   Impact of genomic alterations (GAs) on outcomes and their distribution by age groups in metastatic colorectal cancer (mCRC) patients (pts) [J].
Sahin, Ibrahim Halil ;
Chen, Wanqi H. ;
Chen, Zhengjia ;
Akce, Mehmet ;
Alese, Olatunji B. ;
Shaib, Walid Labib ;
El-Rayes, Bassel F. ;
Wu, Christina .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
[8]   Real-world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer [J].
Xu, Ting ;
Li, Jian ;
Wang, Zhenghang ;
Zhang, Xiaotian ;
Zhou, Jun ;
Lu, Zhihao ;
Shen, Lin ;
Wang, Xicheng .
CANCER MEDICINE, 2023, 12 (09) :10473-10484
[9]   REAL-WORLD TREATMENT PATTERNS, SEQUENCING, AND UNMET NEED IN METASTATIC COLORECTAL CANCER (MCRC) [J].
Desai, K. ;
Shao, C. ;
Li, S. ;
Hair, G. M. ;
Liu, L. ;
Jain, R. ;
Amonkar, M. .
VALUE IN HEALTH, 2024, 27 (06) :S183-S183
[10]   Age-related disparity in treatment outcome and adverse events among patients with metastatic colorectal cancer (mCRC) [J].
Meng, Lingbin ;
Thapa, Ram ;
Xie, Hao .
CANCER RESEARCH, 2022, 82 (12)